You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三諾生物(300298.SZ)擬8522.42萬元收購“慢性疾病健康管理監測產品產能擴建項目”
格隆匯 03-17 20:50

格隆匯3月17日丨三諾生物(300298.SZ)公佈,為進一步優化公司資產配置,公司擬以自有資金購買下屬全資子公司三諾健康管理有限公司(以下簡稱“三諾健康”)委託公司代建的“慢性疾病健康管理監測產品產能擴建項目”名下的相關資產,按經審計後標的資產的賬面淨資產值人民幣8522.42萬元轉讓至上市公司。

該項目建設的目標是建設智能製造生產車間及相關附屬設施,形成年生產血脂、糖化血紅蛋白檢測儀10萬台,配套試條1億支的生產能力,並構建相關健康服務產品的研發能力。目前,該項目建設已經基本完成,已經使用募集資金8,522.42萬元,形成的資產作為在建工程體現在三諾生物。

“慢性疾病健康管理監測產品產能擴建項目”在公司代建完成後,按照三諾健康原有的規劃,該項目將由公司轉移至三諾健康。三諾健康因此需要建立生產、註冊、質保、生產和研發的體系。由於在三諾健康旗下建立獨立相關體系需要支付較大成本和費用,在慢性疾病健康管理監測產品在三諾健康銷售沒有形成規模前,對於全資子公司三諾健康而言,可以充分利用公司的這些體系,降低管理和生產成本。因此,公司決定將三諾健康的“慢性疾病健康管理監測產品產能擴建項目”轉移至公司,充分利用公司的生產、研發和銷售體系,產生最好的效益,同時優化整合公司內部資源,提升公司資產配置及業務專業化管理。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account